BMRN BIOMARIN PHARMACEUTICAL INC: institutional ownership and insider trading
601 funds reported holding $13.5B of BIOMARIN PHARMACEUTICAL INC in their latest 13F filings; in Q2 2026 funds net bought $591M, with 83 new positions and 79 funds selling out; over the last 12 months insiders bought $0 and sold $4.32M on the open market.
Famous investors holding BMRN
- Andreas Halvorsen (Viking Global Investors): $436M, 1.2% of the portfolio
- Ray Dalio (Bridgewater Associates): $15.7M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $121M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $25.9M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $80.3M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $5.28M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.65M, 0.0% of the portfolio
Largest institutional holders of BMRN
- BlackRock, Inc. (BLK) — $1.17B
- VANGUARD GROUP INC — $1.08B
- Banque Cantonale Vaudoise — $916M
- DODGE & COX — $849M
- PRIMECAP MANAGEMENT CO/CA/ — $812M
- VANGUARD CAPITAL MANAGEMENT LLC — $500M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $495M
- NORGES BANK — $470M
- STATE STREET CORP (STT, STT-PG) — $446M
- VIKING GLOBAL INVESTORS LP — $436M
Recent BMRN insider trades
- Sep 2, 2026: Davis George Eric sold 17,557 shares ($1.16M)
- May 7, 2026: Friberg Gregory R sold 3,281 shares ($177K)
- Mar 11, 2026: Guyer Charles Greg sold 16,486 shares ($997K)
- Feb 26, 2026: Davis George Eric sold 26,061 shares ($1.60M)
5%+ owners
- Vanguard Capital Management: 5.3% (Schedule 13G, filed Apr 29, 2026)